Phase II study of docetaxel (DTX) and S-1 as neoadjuvant chemotherapy for potentially R0 advanced gastric cancer.
Yasunori Emi
No relevant relationships to disclose
Eiji Oki
No relevant relationships to disclose
Hiroshi Saeki
No relevant relationships to disclose
Masaru Morita
No relevant relationships to disclose
Tetsuya Kusumoto
No relevant relationships to disclose
Hiroshi Matsuura
No relevant relationships to disclose
Mototsugu Shimokawa
No relevant relationships to disclose
Yoshihiro Kakeji
No relevant relationships to disclose
Hideo Baba
No relevant relationships to disclose
Yoshihiko Maehara
Research Funding - Taiho Pharmaceutical